Neuropace, Inc. · NASDAQ:NPCE
Soleus Capital Management, L.P. reported a 8.90% stake in Neuropace, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 7, 2025
Soleus Capital Management, L.P. reported a 8.90% stake in Neuropace, Inc., 2,948,828 shares, as a passive investor on Sep 30, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 8.90%
- Shares
- 2,948,828
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Private Equity Fund I, L.P. | 0.90% | 310,321 |
| Soleus Private Equity GP I, LLC | 0.90% | 310,321 |
| Soleus PE GP I, LLC | 0.90% | 310,321 |
| Soleus Capital Master Fund, L.P. | 7.90% | 2,638,507 |
| Soleus Capital, LLC | 7.90% | 2,638,507 |
| Soleus Capital Group, LLC | 7.90% | 2,638,507 |
| Soleus Capital Management, L.P. | 8.90% | 2,948,828 |
| Soleus GP, LLC | 8.90% | 2,948,828 |
| Guy Levy | 8.90% | 2,957,957 |